Skip to main content
. 2021 Aug 10;14(11):101197. doi: 10.1016/j.tranon.2021.101197

Fig. 4.

Fig. 4

Genes can be specific for responding or nonresponding patients. (A) Venn diagram of Responder-specific genes from Pembrolizumab- and Nivolumab-treated patients. (B) Heatmap of common Responder-specific genes from Pembrolizumab-treated patients. (C) Heatmap of common Responder-specific genes from Nivolumab-treated patients. (D) Venn diagram of Nonresponder-specific genes from Pembrolizumab- and Nivolumab-treated patients. (E) Heatmap of common Nonresponder-specific genes from Pembrolizumab-treated patients. (F) Heatmap of common Nonresponder-specific genes from Nivolumab-treated patients.